Cargando…

The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis

The dopamine transporter (DAT) is encoded by the SLC6A3 gene and plays an important role in the regulation of the neurotransmitter dopamine. The SLC6A3 gene contains several repetition alleles (3–11 repeats) of a 40-base pair variable number of tandem repeats (VNTR) in the 3′-untranslated region (3′...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qiaoli, Ning, Fan, Gu, Shanshan, Zeng, Qiaodi, Chen, Riling, Peng, Liuquan, Zou, Dehua, Ma, Guoda, Wang, Yajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502797/
https://www.ncbi.nlm.nih.gov/pubmed/34646314
http://dx.doi.org/10.3389/fgene.2021.757601
_version_ 1784580967543865344
author Zeng, Qiaoli
Ning, Fan
Gu, Shanshan
Zeng, Qiaodi
Chen, Riling
Peng, Liuquan
Zou, Dehua
Ma, Guoda
Wang, Yajun
author_facet Zeng, Qiaoli
Ning, Fan
Gu, Shanshan
Zeng, Qiaodi
Chen, Riling
Peng, Liuquan
Zou, Dehua
Ma, Guoda
Wang, Yajun
author_sort Zeng, Qiaoli
collection PubMed
description The dopamine transporter (DAT) is encoded by the SLC6A3 gene and plays an important role in the regulation of the neurotransmitter dopamine. The SLC6A3 gene contains several repetition alleles (3–11 repeats) of a 40-base pair variable number of tandem repeats (VNTR) in the 3′-untranslated region (3′-UTR), which may affect DAT expression levels. The 10-repeat (10R) allele could play a protective role against PD. However, inconsistent findings have been reported. Methods: A comprehensive meta-analysis was performed to accurately estimate the association between the 10R allele of the 3′-UTR VNTR in SLC6A3 and PD among four different genetic models. Results: This meta-analysis included a total of 3,142 patients and 3,496 controls. We observed a significant difference between patients and controls for the allele model (10R vs. all others: OR = 0.860, 95% CI: 0.771–0.958, P = 0.006), pseudodominant model (10R/10R + 10R/9R vs. all others: OR = 0.781, 95% CI: 0.641–0.952, P = 0.014) and pseudorecessive model (10R/10R vs. all others: OR = 0.858, 95% CI: 0.760–0.969, P = 0.013) using a fixed effects model. No significant differences were observed under the pseudocodominant model (10R/9R vs. all others: OR = 1.079, 95% CI: 0.945–1.233, P = 0.262). By subgroup analysis, the 10R, 10R/10R and 10R/9R genotypes were found to be significantly different from PD in Asian populations. Conclusion: Our findings suggest that the SLC6A3 10R may be a protective factor in susceptibility to PD.
format Online
Article
Text
id pubmed-8502797
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85027972021-10-12 The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis Zeng, Qiaoli Ning, Fan Gu, Shanshan Zeng, Qiaodi Chen, Riling Peng, Liuquan Zou, Dehua Ma, Guoda Wang, Yajun Front Genet Genetics The dopamine transporter (DAT) is encoded by the SLC6A3 gene and plays an important role in the regulation of the neurotransmitter dopamine. The SLC6A3 gene contains several repetition alleles (3–11 repeats) of a 40-base pair variable number of tandem repeats (VNTR) in the 3′-untranslated region (3′-UTR), which may affect DAT expression levels. The 10-repeat (10R) allele could play a protective role against PD. However, inconsistent findings have been reported. Methods: A comprehensive meta-analysis was performed to accurately estimate the association between the 10R allele of the 3′-UTR VNTR in SLC6A3 and PD among four different genetic models. Results: This meta-analysis included a total of 3,142 patients and 3,496 controls. We observed a significant difference between patients and controls for the allele model (10R vs. all others: OR = 0.860, 95% CI: 0.771–0.958, P = 0.006), pseudodominant model (10R/10R + 10R/9R vs. all others: OR = 0.781, 95% CI: 0.641–0.952, P = 0.014) and pseudorecessive model (10R/10R vs. all others: OR = 0.858, 95% CI: 0.760–0.969, P = 0.013) using a fixed effects model. No significant differences were observed under the pseudocodominant model (10R/9R vs. all others: OR = 1.079, 95% CI: 0.945–1.233, P = 0.262). By subgroup analysis, the 10R, 10R/10R and 10R/9R genotypes were found to be significantly different from PD in Asian populations. Conclusion: Our findings suggest that the SLC6A3 10R may be a protective factor in susceptibility to PD. Frontiers Media S.A. 2021-09-27 /pmc/articles/PMC8502797/ /pubmed/34646314 http://dx.doi.org/10.3389/fgene.2021.757601 Text en Copyright © 2021 Zeng, Ning, Gu, Zeng, Chen, Peng, Zou, Ma and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Zeng, Qiaoli
Ning, Fan
Gu, Shanshan
Zeng, Qiaodi
Chen, Riling
Peng, Liuquan
Zou, Dehua
Ma, Guoda
Wang, Yajun
The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis
title The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis
title_full The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis
title_fullStr The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis
title_full_unstemmed The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis
title_short The 10-Repeat 3′-UTR VNTR Polymorphism in the SLC6A3 Gene May Confer Protection Against Parkinson’s Disease: A Meta-analysis
title_sort 10-repeat 3′-utr vntr polymorphism in the slc6a3 gene may confer protection against parkinson’s disease: a meta-analysis
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502797/
https://www.ncbi.nlm.nih.gov/pubmed/34646314
http://dx.doi.org/10.3389/fgene.2021.757601
work_keys_str_mv AT zengqiaoli the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT ningfan the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT gushanshan the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT zengqiaodi the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT chenriling the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT pengliuquan the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT zoudehua the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT maguoda the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT wangyajun the10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT zengqiaoli 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT ningfan 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT gushanshan 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT zengqiaodi 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT chenriling 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT pengliuquan 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT zoudehua 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT maguoda 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis
AT wangyajun 10repeat3utrvntrpolymorphismintheslc6a3genemayconferprotectionagainstparkinsonsdiseaseametaanalysis